Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis

American Journal of Hematology

Volumn 58, Issue 1, 1998, Pages 16-19

  Adams, Paul C ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Genetic hemochromatosis; Iron mobilization; Venesection therapy

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; INTESTINE ABSORPTION; IRON ABSORPTION; IRON KINETICS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOLOGICAL TRANSPORT; FEMALE; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRON; MALE; MIDDLE AGED; MUTATION; PHLEBOTOMY;

EID: 0031899650     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199805)58:1<16::AID-AJH3>3.0.CO;2-3     Document Type: Article

References (23)

1. Crosby WH: A history of phlebotomy therapy for hemochromatosis. Am J Med Sci 301:28-31, 1991.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al: A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genet 13:399-408, 1996.
3. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP: Haemochromatosis and HLA-H. Nature Genet 14:249-251, 1996.
4. Adams PC, Chakrabarti S: Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria (abstract). Gastroenterology 114:319-323, 1998.
5. Adams PC, Frei JV, Bradley C, Lam D: Hepatic iron and iron absorption in hemochromatosis. Clin Invest Med 13:256-258, 1990.
6. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6:24-29, 1986.
7. Bomford A, Williams R: Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med 45:611-623, 1976.
8. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB: Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med 93: 519-525, 1980.
9. Candell-Riera J, Lu L, Seres L, Gonzalez JB, Batlle J, Permanyer-Miralda G, Garcia-del-Castillo H, Soler-Soler J: Cardiac hemochromatosis: Beneficial effects of iron removal therapy. An echocardiographic study. Am J Cardiol 52:824-829, 1983.
10. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G: Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107-1119, 1996.
11. Adams PC, Valberg LS: Evolving expression of hereditary hemochromatosis. Semin Liver Dis 16:47-54, 1996.
12. Mostert LJ, de Jong G, Koster JF, van Eijk HG: Iron mobilization from isolated hepatocytes. Int J Biochem 18:1061-1064, 1986.
13. Gabbe EE, Fischer RF, Heinrich HC: Iron-59 retention kinetics during exhaustive phlebotomy treatment of hereditary hemochromatosis. Ann NY Acad Sci 526:342-345, 1988.
14. Muir WA, McLaren GD, Braun W, Askari A: Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Am J Med 76:806-814, 1984.
15. Adams PC: Intrafamilial variation in hereditary hemochromatosis. Dig Dis Sci 37:361-363, 1992.
16. Adams PC, Kertesz AE, Valberg LS: Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy. J Clin Gastroenterol 16:207-210, 1993.
17. Olynyk JK, Luxon BA, Jeffrey GP, Reed WD, Bacon BR: Predicting phlebotomy requirements in the treatment of iron overload (Abstract). Hepatology 20:323A, 1994.
18. Finch C: Regulators of iron balance in humans. Blood 84:1697-1702, 1994.
19. Adams PC, Chau LA, Lin E, Muirhead N: The effect of human recombinant erythropoietin on iron absorption and hepatic iron in a rat model. Clin Invest Med 14:432-436, 1991.
20. van Oost BA, van den Beld B, van Asbeck BS. Marx JJM: Monitoring of intensive phlebotomy therapy in iron overload by serum ferritin assay. Am J Hematol 18:7-12, 1985.
21. Milder MS, Cook JD, Stray S, Finch CA: Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 59:34-49, 1980.
22. Williams R, Smith PM, Spicer EJ, Barry M, Sherlock S: Venesection therapy in idiopathic hemochromatosis. An analysis of 40 treated and 18 untreated patients. Q J Med 38:1-16, 1969.
23. Piperno A, Arosio C, Fargion S, Roetto A, Nicoli C, Girelli D, Sbaiz L, Gasparini P, Boari G, Sampietro M, Camaschella C: The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology 24:43-46, 1996.